Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Moderna, BioNTech Plunge As EU Studies Possible Side-effects Of mRNA Shots

Published 2021-08-11, 01:38 p/m
Updated 2021-08-11, 01:38 p/m
© Reuters

By Dhirendra Tripathi

Investing.com – Moderna (NASDAQ:MRNA) and BioNTech stocks (NASDAQ:BNTX) slumped by 15% each Wednesday on a report that Europe’s drug regulator is studying three new conditions reported by a small number of people after vaccination with Covid-19 shots to assess if they may be possible side-effects.

The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.

Pfizer stock fell 3%. Expenses and profit from the Covid vaccine are split equally between Pfizer (NYSE:PFE) and BioNTech.

BioNTech-Pfizer is the biggest supplier of Covid-19 vaccines to Europe.

Just over 43.5 million doses of Moderna's vaccine have been administered in the European Economic Area as of July 29, the EMA said, compared to more than 330 million doses of the BioNTech-Pfizer shot.

 

 

Latest comments

they are quackcines not vaccines and they are meant for trans humanism , not a "virus" which does not exist
Normal
it's just a report everything is fine
Let us know when you are back on Earth, Jamie!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.